TN HB2002 | 2017-2018 | 110th General Assembly
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Republican 6-1)
Status: Passed on April 17 2018 - 100% progression
Action: 2018-04-17 - Pub. Ch. 674
Text: Latest bill text (Chaptered) [PDF]
Spectrum: Moderate Partisan Bill (Republican 6-1)
Status: Passed on April 17 2018 - 100% progression
Action: 2018-04-17 - Pub. Ch. 674
Text: Latest bill text (Chaptered) [PDF]
Summary
As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Title
As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Sponsors
Rep. Bryan Terry [R] | Rep. David Hawk [R] | Rep. Cameron Sexton [R] | Rep. Sabi Kumar [R] |
Rep. JoAnne Favors [D] | Rep. John Ragan [R] | Rep. Dennis Powers [R] |
Roll Calls
2018-04-02 - Senate - FLOOR VOTE: Third Consideration (Y: 33 N: 0 NV: 0 Abs: 0) [FAIL]
2018-03-05 - House - FLOOR VOTE: AS AMENDED PASSAGE ON THIRD CONSIDERATION (Y: 96 N: 0 NV: 0 Abs: 0) [FAIL]
2018-03-05 - House - FLOOR VOTE: AS AMENDED PASSAGE ON THIRD CONSIDERATION (Y: 96 N: 0 NV: 0 Abs: 0) [FAIL]
History
Date | Chamber | Action |
---|---|---|
2018-04-17 | Pub. Ch. 674 | |
2018-04-17 | Effective date(s) 04/12/2018 | |
2018-04-12 | Signed by Governor. | |
2018-04-06 | House | Transmitted to Governor for his action. |
2018-04-05 | Senate | Signed by Senate Speaker |
2018-04-04 | House | Signed by H. Speaker |
2018-04-03 | House | Enrolled; ready for sig. of H. Speaker. |
2018-04-02 | Senate | Passed Senate, Ayes 33, Nays 0 |
2018-04-02 | Senate | Amendment withdrawn. (Amendment 1 - SA0724) |
2018-04-02 | Senate | Senate substituted House Bill for companion Senate Bill. |
2018-03-08 | Senate | Received from House, Passed on First Consideration |
2018-03-06 | House | Engrossed; ready for transmission to Sen. |
2018-03-05 | House | Sponsor(s) Added. |
2018-03-05 | House | Passed H., as am., Ayes 96, Nays 0, PNV 0 |
2018-03-05 | House | H. adopted am. (Amendment 1 - HA0730) |
2018-03-01 | House | H. Placed on Regular Calendar for 3/5/2018 |
2018-02-28 | House | Placed on cal. Calendar & Rules Committee for 3/1/2018 |
2018-02-27 | House | Rec. for pass. if am., ref. to Calendar & Rules Committee |
2018-02-26 | House | Sponsor(s) Added. |
2018-02-21 | House | Placed on cal. Health Committee for 2/27/2018 |
2018-02-21 | House | Rec for pass if am by s/c ref. to Health Committee |
2018-02-14 | House | Placed on s/c cal Health Subcommittee for 2/21/2018 |
2018-02-14 | House | Action Def. in s/c Health Subcommittee to 2/21/2018 |
2018-02-07 | House | Placed on s/c cal Health Subcommittee for 2/14/2018 |
2018-02-05 | House | Assigned to s/c Health Subcommittee |
2018-02-01 | House | P2C, ref. to Health Committee |
2018-01-31 | House | Intro., P1C. |
2018-01-29 | House | Filed for intro. |
Same As/Similar To
SB2099 (Crossfiled) 2018-04-17 - Comp. became Pub. Ch. 674